Lorcaserin para el tratamiento de la obesidad. Déjà vu?


¨The history of pharmacologic treatment of obesity is characterized by repetition: most drugs that have achieved regulatory approvaland reached the markets have subsequently been withdrawn owing to postmarketing discovery of serious adverse effects.¨

No hay comentarios.: